Can-Fite BioPharma Ltd. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Can-Fite BioPharma Ltd. (CANF) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 8.00 thousand shares for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-03-26
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|
| 2025-12-31 | 8.00K shares 20-F · filed 2026-03-26 | |
| 2025-06-30 | 24.00M shares 6-K · filed 2025-08-28 | |
| 2024-12-31 | 50.00M shares 20-F · filed 2025-04-14 | |
| 2024-06-30 | 9.00M shares 6-K · filed 2024-08-29 | |
| 2023-12-31 | 55.50M shares 20-F · filed 2024-03-28 | |
| 2023-06-30 | 15.50M shares 6-K · filed 2023-08-31 | |
| 2022-12-31 | 8.75M shares 20-F · filed 2023-03-30 | |
| 2021-12-31 | 7.10M shares 20-F · filed 2022-03-24 | |
| 2020-12-31 | 9.25M shares 20-F · filed 2021-03-25 | |
| 2019-12-31 | 1.24M shares 20-F · filed 2021-03-25 |